Perianal Crohn’s Disease: Recognition and Treatment Paths

Perianal Crohn’s disease represents one of the most challenging manifestations of inflammatory bowel disease, affecting 35-45% of Crohn’s patients throughout their disease course. This variant involves inflammation, fistulas, abscesses, and tissue damage around the anal region, significantly impacting quality of life and requiring specialized management strategies. Unlike standard intestinal Crohn’s, perianal involvement demands immediate recognition and aggressive treatment to prevent permanent complications and preserve function.

Why Perianal Involvement Signals Aggressive Disease Behavior

When Crohn’s disease affects the perianal region, it often indicates a more aggressive disease phenotype that requires heightened surveillance and proactive treatment. This isn’t simply another symptom to manage it’s a clinical marker that gastroenterologists recognize as a red flag for complicated disease progression. Perianal manifestations often appear early in the disease course, sometimes preceding intestinal symptoms by months or even years.

According to Webmd, perianal Crohn’s disease affects a substantial portion of the Crohn’s population, with prevalence estimates varying based on disease duration and geographic location. The presence of perianal fistulizing Crohn’s correlates strongly with a more severe disease phenotype that tends to involve multiple segments of the digestive tract simultaneously. Patients with anorectal Crohn’s complications often experience earlier onset of disease and have a higher likelihood of requiring surgical intervention throughout their lifetime.

@keyframes hoox-lf-in-hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top {
from { opacity: 0; transform: translateY(8px); }
to { opacity: 1; transform: translateY(0); }
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top {
width: 100%;
max-width: 100%;
box-sizing: border-box;
display: flex;
flex-direction: column;
gap: 20px;
margin: 48px 0;
padding: 32px 28px;
border-radius: 16px;
background: #ffffff;
color: #111111;
font-family: inherit;
border: 1px solid #E2E8F0;
animation: hoox-lf-in-hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top 0.3s cubic-bezier(0.16, 1, 0.3, 1);
direction: inherit;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-form-header {
display: flex;
flex-direction: column;
gap: 8px;
text-align: center;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-form-header h2 {
margin: 0;
font-size: 1.5em;
font-weight: 700;
line-height: 1.3;
color: #111111;
border: none;
padding: 0;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-form-header p {
margin: 0;
font-size: 1em;
line-height: 1.6;
color: #64748B;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top form[data-hx-form] {
margin: 0;
display: flex;
flex-direction: column;
gap: 14px;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-field-wrap {
position: relative;
width: 100%;
box-sizing: border-box;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-field-wrap input {
width: 100%;
box-sizing: border-box;
height: 44px;
padding-inline-start: 42px;
padding-inline-end: 14px;
border: 1px solid #E2E8F0;
border-radius: 10px;
font-size: 14px;
color: #111111;
font-family: inherit;
background-color: #F8FAFC;
transition: border-color 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
outline: none;
direction: inherit;
text-align: start;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-field-wrap input::placeholder {
color: #94A3B8;
opacity: 1;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-field-wrap input:focus {
background-color: #FFFFFF;
border-color: #0077B6,#00B4D8,#90E0EF;
box-shadow: 0 0 0 3px rgba(15, 23, 42, 0.08);
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-field-icon {
position: absolute;
top: 0;
bottom: 0;
inset-inline-start: 0;
width: 42px;
display: flex;
align-items: center;
justify-content: center;
pointer-events: none;
color: #94A3B8;
transition: color 0.15s ease;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-field-wrap:focus-within .hoox-field-icon {
color: #0077B6,#00B4D8,#90E0EF;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top button[type=”submit”] {
width: 100%;
height: 44px;
margin-top: 4px;
border: none;
border-radius: 10px;
background: #0077B6,#00B4D8,#90E0EF;
color: #FFFFFF;
font-size: 14px;
font-weight: 600;
cursor: pointer;
transition: opacity 0.15s ease, transform 0.15s ease, box-shadow 0.15s ease;
box-shadow: 0 1px 2px 0 rgba(0, 0, 0, 0.05);
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top button[type=”submit”]:hover {
opacity: 0.94;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top button[type=”submit”]:active {
transform: scale(0.99);
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top button[type=”submit”]:disabled {
opacity: 0.6;
cursor: not-allowed;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-disclaimer {
margin: 0;
text-align: center;
font-size: 12px;
line-height: 1.5;
color: #94A3B8;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-disclaimer a {
color: inherit;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-disclaimer a:hover {
text-decoration: none;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-success {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
position: relative;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-confetti {
position: absolute;
inset: 0;
overflow: visible;
pointer-events: none;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-confetti span {
position: absolute;
top: 50%;
left: 50%;
width: 7px;
height: 11px;
background: var(–hoox-c);
border-radius: 2px;
opacity: 0;
animation: hoox-confetti-burst 0.9s ease-out forwards;
animation-delay: var(–hoox-d, 0s);
}

@keyframes hoox-confetti-burst {
0% { opacity: 1; transform: translate(-50%, -50%) rotate(0deg) scale(1); }
100% { opacity: 0; transform: translate(calc(-50% + var(–hoox-tx)), calc(-50% + var(–hoox-ty))) rotate(var(–hoox-rz)) scale(0.5); }
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-success-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #ECFDF5;
display: flex;
align-items: center;
justify-content: center;
font-size: 26px;
line-height: 1;
animation: hoox-success-pop 0.4s cubic-bezier(0.34, 1.56, 0.64, 1);
}

@keyframes hoox-success-pop {
from { opacity: 0; transform: scale(0.5); }
to { opacity: 1; transform: scale(1); }
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-success-text {
margin: 0;
text-align: center;
font-size: 15px;
font-weight: 600;
line-height: 1.5;
color: #111111;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-disabled-state {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
text-align: center;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-disabled-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #F1F5F9;
display: flex;
align-items: center;
justify-content: center;
color: #64748B;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-disabled-text {
margin: 0;
font-size: 14px;
line-height: 1.6;
color: #64748B;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-disabled-text a {
color: inherit;
font-weight: 600;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-top .hoox-disabled-text a:hover {
text-decoration: none;
}

The pathophysiology behind perianal involvement reveals why this manifestation proves so problematic. Crohn’s disease creates transmural inflammation meaning it penetrates through all layers of the intestinal wall rather than staying superficial. When this inflammatory process reaches the anal canal and surrounding tissues, it creates ideal conditions for inflammatory bowel disease manifestations that include abscess formation, fistula development, and tissue scarring. The anal region contains numerous glands and crypts that become entry points for bacteria, perpetuating a cycle of infection and chronic inflammation that proves difficult to break without comprehensive treatment.

Research demonstrates that patients with perianal involvement face distinct challenges compared to those with purely luminal disease. The fistula Crohn’s disease phenotype tends to cluster in families, suggesting a genetic component to disease severity. Additionally, perianal manifestations inflammatory bowel patterns often correlate with other extra-intestinal manifestations, including joint pain, skin lesions, and eye inflammation. This clustering effect reinforces the need for systemic treatment approaches rather than localized symptom management alone.

Quick Answer: Distinguishing Perianal Symptoms From Standard Hemorrhoids

Many patients initially mistake perianal Crohn’s symptoms for common hemorrhoids, leading to delayed diagnosis and progression of disease. Understanding the distinction empowers patients to seek appropriate evaluation earlier, when treatment proves most effective. The key differentiator lies in the persistence, progression, and associated symptoms that accompany true perianal Crohn’s involvement.

Symptom Characteristic	Perianal Crohn’s Disease	Common Hemorrhoids
Pain Pattern	Constant, deep throbbing; worsens with sitting	Intermittent; worse during bowel movements
Drainage	Purulent, foul-smelling discharge from openings	Bright red bleeding, no pus
Skin Changes	Multiple tags, induration, discoloration	Single swollen vein, bluish tint
Response to Treatment	Poor response to standard hemorrhoid therapy	Improves with conservative measures
Associated Symptoms	Abdominal pain, diarrhea, weight loss	Isolated to perianal region
Healing Pattern	Chronic, non-healing wounds	Heals within days to weeks

Perianal skin tags Crohn’s patients experience differ significantly from typical external hemorrhoids. These tags often appear edematous, feel firm or indurated, and may have a “woody” texture on examination. Unlike hemorrhoidal tissue that compresses easily, Crohn’s-related tags feel rigid and may surround the anal opening in a pattern described as “elephant ears.” Biopsy of these lesions reveals granulomatous inflammation the hallmark of Crohn’s disease rather than the simple vascular dilation seen in hemorrhoids.

Perianal abscess IBD patients develop often presents with systemic signs that hemorrhoids never cause. Fever, malaise, and elevated inflammatory markers accompany true abscess formation. The pain from a perianal abscess tends to be constant and severe enough to interfere with sleep, whereas hemorrhoidal pain typically relates directly to bowel movements and settles afterward. Any patient experiencing persistent perianal pain with systemic symptoms should seek immediate evaluation, as abscesses require drainage to prevent sepsis and fistula formation.

For those seeking Crohn’s disease treatment options, recognizing these distinctions early opens doors to more effective interventions. Delayed recognition allows fistulous tracts to mature and branch, making subsequent treatment considerably more complex. The window for achieving remission narrows as chronic inflammation creates fibrotic tissue that resists medical therapy.

The Fistula Problem: Why Medical Therapy Achieves Only 33% Durable Remission

Fistulas represent the most challenging aspect of perianal Crohn’s disease, and the statistics regarding treatment success can feel sobering. According to Nih, among patients with perianal fistulizing Crohn’s disease, medical therapy achieves durable remission in only about one-third of patients. This reality forces both patients and physicians to confront uncomfortable truths about the limitations of current treatment approaches while maintaining hope for better outcomes through comprehensive management.

The anatomy of a Crohn’s perianal fistula explains why these structures prove so resistant to treatment. A fistula is essentially an abnormal tunnel connecting an internal opening in the anal canal to one or more external openings on the perianal skin. This tract becomes lined with epithelium over time, creating a permanent pathway for drainage unless actively treated. Simple fistulas have a single tract with a single external opening, while complex fistulas branch like tree roots, may involve multiple sphincter muscles, and can include abscess cavities along their course.

Medical therapy alone struggles against mature fistulous tracts because anti-inflammatory medications cannot easily penetrate fibrotic, scarred tissue. The blood supply to established fistula tracts proves poor, limiting drug delivery to the site where it’s needed most. Additionally, the bacterial contamination inherent in anorectal locations perpetuates inflammation even when systemic disease activity improves. This disconnect between luminal healing and fistula persistence frustrates patients who otherwise respond well to treatment.

Understanding patient experiences with treatment approaches reveals the emotional toll this therapeutic gap creates. Many patients feel trapped between medications that control their intestinal symptoms but leave them with ongoing perianal drainage, discomfort, and infection risk. The need for combination therapy medical and surgical becomes apparent early in most treatment courses, though patients often hope to avoid additional procedures.

How To Build a Perianal Management Protocol With Your Gastroenterologist

Successful management of perianal Crohn’s requires a coordinated approach that brings together medical therapy, surgical intervention, and ongoing symptom management. Building an effective protocol with your gastroenterologist means understanding the sequence of evaluation, the timing of critical interventions, and your role in monitoring for treatment response or complications.

• Establish Baseline Imaging: Request pelvic MRI with rectal contrast as the gold standard for mapping fistula anatomy before treatment begins.
• Coordinate Initial Surgical Evaluation: Meet with a colorectal surgeon experienced in Crohn’s disease within the first month of diagnosis for examination under anesthesia if active fistulas are suspected.
• Document Complete Fistula Anatomy: Ensure your care team identifies all internal openings, external openings, and secondary tracts partial mapping leads to treatment failure.
• Initiate Biological Therapy Promptly: Start TNF-α blocker therapy within weeks of diagnosis for confirmed perianal disease, as delayed treatment correlates with worse outcomes.
• Address Acute Abscesses First: Any fluctuant, tender swelling requires surgical drainage before meaningful medical therapy can proceed.
• Implement Scheduled Seton Management: Work with your surgeon to place appropriate draining setons and maintain them until the tract heals from inside out.

The coordination between gastroenterology and colorectal surgery proves critical because medical therapy works best on actively inflamed tissue that still has healing potential, while surgical therapy addresses mechanical problems like abscesses and established fistula tracts. Neither specialty alone provides optimal care integrated management delivers superior results.是你的

Patients often benefit from natural supplements supporting digestive inflammation as part of a comprehensive approach. While supplements cannot replace biological therapy for established fistulas, supporting overall gut health may improve medication efficacy and reduce systemic inflammatory burden.

Biologic Therapy Selection: TNF-α Blockers and Beyond for Perianal Disease

Biological therapy forms the cornerstone of medical treatment for perianal Crohn’s disease, with anti-tumor necrosis factor alpha (TNF-α) agents demonstrating the strongest evidence base for fistula healing. Understanding the options, their mechanisms, and their specific applications in perianal disease empowers patients to participate meaningfully in treatment decisions.

Infliximab (Remicade) and adalimumab (Humira) represent the two most studied TNF-α blockers for perianal fistulizing disease. Infliximab, administered as intravenous infusions, has demonstrated fistula response rates approaching 70% in clinical trials, with complete fistula closure achieved in approximately one-third of patients. The infusion format allows for precise dosing adjustment and management of infusion reactions under direct medical supervision. Adalimumab offers the convenience of subcutaneous self-administration, though some data suggests slightly lower efficacy for perianal disease specifically.

Agent Category	Examples	Perianal Evidence Strength	Administration Route
Anti-TNF-α	Infliximab, Adalimumab, Certolizumab	Strongest clinical trial data	IV infusion or subcutaneous
Anti-Integrin	Vedolizumab	Limited perianal-specific data	IV infusion
Anti-IL-12/23	Ustekinumab	Emerging perianal evidence	IV loading, subcutaneous maintenance
JAK Inhibitor	Upadacitinib	Limited perianal-specific data	Oral

Newer biological agents offer alternatives when TNF-α blockers fail or cause adverse effects, though perianal-specific data remains more limited. Ustekinumab, which blocks interleukin-12 and interleukin-23, has shown promise for luminal Crohn’s disease and may provide benefit for perianal involvement. However, current guidelines reserve these agents for patients who cannot tolerate or have lost response to anti-TNF therapy.

For patients interested in integrative approaches to digestive inflammation, certain natural compounds have demonstrated TNF-α modulating properties in laboratory studies. While these should never replace prescribed biological therapy, understanding that natural options exist for supporting inflammatory balance can help patients feel more in control of their overall treatment picture.

Surgical Options When Conservative Management Fails Perianal Fistulas

Surgery plays an indispensable role in perianal Crohn’s management, often in combination with medical therapy rather than as a last resort. Understanding the available procedures, their indications, and realistic expectations helps patients approach surgical discussions with their colorectal surgeon from an informed perspective.

Seton placement represents the most common surgical intervention for perianal fistulizing Crohn’s. A seton is a flexible thread passed through the fistula tract that remains in place to maintain drainage and prevent abscess formation. Draining setons stay in place long-term, allowing the tract to mature and surrounding inflammation to settle before definitive repair. Cutting setons slowly tighten over time, gradually cutting through the sphincter muscle while the muscle heals behind it though cutting setons carry higher risk of incontinence and see less use in Crohn’s patients.

Definitive surgical procedures include fistulotomy, mucosal advancement flaps, and the LIFT (ligation of intersphincteric fistula tract) procedure. Fistulotomy opening the tract entirely and allowing it to heal from the bottom up works well for superficial fistulas but carries unacceptable incontinence risk when significant sphincter muscle involvement exists. Advancement flaps cover the internal opening with healthy tissue from higher in the rectum, achieving success rates of 50-70% in carefully selected patients. The LIFT procedure avoids dividing sphincter muscle entirely, making it attractive for preserving continence, though long-term success rates vary widely.

Patients exploring complementary treatment solutions should maintain realistic expectations about what natural approaches can achieve for established fistulas. No supplement or herb can close a mature fistula tract that requires either surgical intervention or the combination of biological therapy with sufficient time for healing from within.

Key Takeaways: Living With and Managing Perianal Crohn’s Effectively

Managing perianal Crohn’s disease demands a long-term perspective that acknowledges challenges while maintaining hope. Advances in both medical and surgical treatment have transformed outcomes for many patients, though achieving remission requires patience, persistence, and close collaboration with experienced specialists.

• Early Recognition Matters: Persistent perianal pain, drainage, or non-healing lesions warrant immediate evaluation waiting allows fistulas to mature and treatment success to decline.
• Combination Therapy Outperforms Either Approach Alone: Medical therapy treats systemic inflammation while surgery addresses mechanical problems; together they achieve better results than either in isolation.
• MRI Mapping Guides All Treatment Decisions: Understanding complete fistula anatomy before treatment begins prevents inadequate therapy and premature surgical failure.
• Setons Are Often Long-Term Partners in Healing: Maintaining draining setons for months to years proves necessary for complex disease; embracing this reality reduces frustration.
• Preserving Continence Guides Every Decision: Aggressive surgical approaches that sacrifice sphincter function create problems worse than the fistula itself; conservative staged approaches protect quality of life.

For our approach to supporting IBD patients, Kronlitis recognizes that perianal involvement creates unique challenges that extend beyond intestinal inflammation. Our German-manufactured supplement contains four herbs specifically selected for their anti-inflammatory properties, designed to support conventional medical therapy rather than replace it. Understanding that comprehensive care addresses both systemic inflammation and local perianal disease helps patients achieve the best possible outcomes.

FAQ: Perianal Crohn’s Disease Questions

Will I definitely need surgery for perianal fistulas?

No, not all patients require definitive surgical repair. Approximately 30-40% of patients achieve meaningful fistula improvement with medical therapy alone, particularly when treatment begins early. However, most patients benefit from at least seton placement to control drainage and prevent abscess formation while medical therapy takes effect. Surgical intervention bridges the gap when medications cannot close fistulous tracts on their own.

How long does fistula healing typically take with biological therapy?

Most studies evaluate fistula response at 12-14 weeks of therapy. Complete closure, when it occurs, typically requires 6-12 months of continuous treatment. Some patients continue draining setons throughout this period, with seton removal attempted once drainage has stopped for several months and MRI confirms tract closure. Patience proves essential rushing seton removal often leads to abscess recurrence.

Can I maintain normal intimacy and relationships with perianal disease?

Yes, though adjustments and communication become necessary. Perianal disease affects intimacy through physical discomfort, drainage concerns, and emotional impact on body image. Open discussion with partners, timing intimacy around periods of minimal symptoms, and addressing drainage with appropriate hygiene products helps maintain relationships. Many patients report that partners prove more understanding than anticipated once the medical reality is explained.

Will perianal fistulas ever completely heal?

Complete healing remains possible for many patients. Defined as lasting closure without need for ongoing drainage intervention, durable remission occurs in about one-third of patients with combination therapy. Higher rates of healing occur with earlier treatment, simpler fistula anatomy, and careful surgical technique. However, some patients require ongoing management with draining setons or periodic procedures to maintain function and quality of life.

Does perianal involvement affect my overall Crohn’s prognosis?

Yes, perianal disease correlates with more aggressive overall disease behavior. Patients with perianal involvement tend to have more extensive intestinal disease, higher rates of complications like strictures and penetration, and greater likelihood of requiring multiple surgeries. This correlation reinforces the importance of comprehensive treatment that addresses both systemic disease activity and local perianal pathology simultaneously.

Can I use natural supplements alongside my prescribed Crohn’s medications?

Many patients successfully incorporate natural supplements as supportive therapy. Kronlitis, manufactured in Germany with quality standards and shipped worldwide, contains four herbs traditionally used for inflammatory bowel conditions. Always discuss supplements with your gastroenterologist to ensure no interactions with biological therapy. Supplements work best as part of comprehensive care rather than替代 prescribed treatment for active perianal disease.

@keyframes hoox-lf-in-hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom {
from { opacity: 0; transform: translateY(8px); }
to { opacity: 1; transform: translateY(0); }
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom {
width: 100%;
max-width: 100%;
box-sizing: border-box;
display: flex;
flex-direction: column;
gap: 20px;
margin: 48px 0;
padding: 32px 28px;
border-radius: 16px;
background: #ffffff;
color: #111111;
font-family: inherit;
border: 1px solid #E2E8F0;
animation: hoox-lf-in-hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom 0.3s cubic-bezier(0.16, 1, 0.3, 1);
direction: inherit;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-form-header {
display: flex;
flex-direction: column;
gap: 8px;
text-align: center;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-form-header h2 {
margin: 0;
font-size: 1.5em;
font-weight: 700;
line-height: 1.3;
color: #111111;
border: none;
padding: 0;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-form-header p {
margin: 0;
font-size: 1em;
line-height: 1.6;
color: #64748B;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom form[data-hx-form] {
margin: 0;
display: flex;
flex-direction: column;
gap: 14px;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-field-wrap {
position: relative;
width: 100%;
box-sizing: border-box;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-field-wrap input {
width: 100%;
box-sizing: border-box;
height: 44px;
padding-inline-start: 42px;
padding-inline-end: 14px;
border: 1px solid #E2E8F0;
border-radius: 10px;
font-size: 14px;
color: #111111;
font-family: inherit;
background-color: #F8FAFC;
transition: border-color 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
outline: none;
direction: inherit;
text-align: start;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-field-wrap input::placeholder {
color: #94A3B8;
opacity: 1;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-field-wrap input:focus {
background-color: #FFFFFF;
border-color: #0077B6,#00B4D8,#90E0EF;
box-shadow: 0 0 0 3px rgba(15, 23, 42, 0.08);
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-field-icon {
position: absolute;
top: 0;
bottom: 0;
inset-inline-start: 0;
width: 42px;
display: flex;
align-items: center;
justify-content: center;
pointer-events: none;
color: #94A3B8;
transition: color 0.15s ease;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-field-wrap:focus-within .hoox-field-icon {
color: #0077B6,#00B4D8,#90E0EF;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom button[type=”submit”] {
width: 100%;
height: 44px;
margin-top: 4px;
border: none;
border-radius: 10px;
background: #0077B6,#00B4D8,#90E0EF;
color: #FFFFFF;
font-size: 14px;
font-weight: 600;
cursor: pointer;
transition: opacity 0.15s ease, transform 0.15s ease, box-shadow 0.15s ease;
box-shadow: 0 1px 2px 0 rgba(0, 0, 0, 0.05);
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom button[type=”submit”]:hover {
opacity: 0.94;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom button[type=”submit”]:active {
transform: scale(0.99);
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom button[type=”submit”]:disabled {
opacity: 0.6;
cursor: not-allowed;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-disclaimer {
margin: 0;
text-align: center;
font-size: 12px;
line-height: 1.5;
color: #94A3B8;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-disclaimer a {
color: inherit;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-disclaimer a:hover {
text-decoration: none;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-success {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
position: relative;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-confetti {
position: absolute;
inset: 0;
overflow: visible;
pointer-events: none;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-confetti span {
position: absolute;
top: 50%;
left: 50%;
width: 7px;
height: 11px;
background: var(–hoox-c);
border-radius: 2px;
opacity: 0;
animation: hoox-confetti-burst 0.9s ease-out forwards;
animation-delay: var(–hoox-d, 0s);
}

@keyframes hoox-confetti-burst {
0% { opacity: 1; transform: translate(-50%, -50%) rotate(0deg) scale(1); }
100% { opacity: 0; transform: translate(calc(-50% + var(–hoox-tx)), calc(-50% + var(–hoox-ty))) rotate(var(–hoox-rz)) scale(0.5); }
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-success-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #ECFDF5;
display: flex;
align-items: center;
justify-content: center;
font-size: 26px;
line-height: 1;
animation: hoox-success-pop 0.4s cubic-bezier(0.34, 1.56, 0.64, 1);
}

@keyframes hoox-success-pop {
from { opacity: 0; transform: scale(0.5); }
to { opacity: 1; transform: scale(1); }
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-success-text {
margin: 0;
text-align: center;
font-size: 15px;
font-weight: 600;
line-height: 1.5;
color: #111111;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-disabled-state {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
text-align: center;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-disabled-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #F1F5F9;
display: flex;
align-items: center;
justify-content: center;
color: #64748B;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-disabled-text {
margin: 0;
font-size: 14px;
line-height: 1.6;
color: #64748B;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-disabled-text a {
color: inherit;
font-weight: 600;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-2845f7a2-ec29-4d78-9f77-fea1c0-bottom .hoox-disabled-text a:hover {
text-decoration: none;
}